We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of Prescribing for Diabetes
Prescribing for Diabetes in England - 2005/06 to 2010/11Official statistics
- Publication Date:
- 24 Aug 2011
- Geographic Coverage:
- Geographical Granularity:
- Country, Primary Care Trusts, Clinical Commissioning Groups, Primary Care Organisations
- Date Range:
- 01 Apr 2005 to 31 Mar 2011
This report is the latest in a series of publications on diabetes by The NHS Information Centre. It covers the period 2005/06 to 2010/11.
- Diabetes prevalence in England increased from 3.6 per cent in 2005/6 to 4.3 per cent in 2009/10.
- 'Drugs for diabetes' is the BNF section of highest cost and greatest increase in cost in primary care in England over the last year.
- In 2010/11 there were 38.3 million items prescribed for diabetes at a net ingredient cost of £725.1 million.
- Prescribing for diabetes accounted for 4.1 per cent of items and 8.4 per cent of the total cost of prescribing in 2010/11 compared with 3.7 per cent and 6.6 per cent in 2005/6.
- Use of oral antidiabetic metformin rose from 8.6 million items in 2005/6 to 14.6 million items in 2010/11. This follows NICE's recommendation that this drug should be first choice for oral therapy.
NHS BSA, Quality and Outcomes Framework,ePACT, QOF, NDA
Last edited: 27 June 2018 9:33 am